TriNetX Acquires Advera Health Analytics

Advarra Acquires YourEncore

January 7, 2021

Healthcare Services

Advarra has acquired YourEncore, a provider of drug development and commercialization advisory and consulting services. The acquisition expands Advarra's consulting capabilities—combining YourEncore's centers of excellence in quality, regulatory, and clinical with Advarra's IRB, IBC review and clinical site technology offerings to better serve biopharmaceutical sponsors, device manufacturers and academic medical centers.

Veranex (backed by Summit Partners) Forms Platform and Acquires Ximedica, Quartesian, and Boston Healthcare Associates

June 16, 2021

Healthcare Services

Veranex, formed in partnership with growth investor Summit Partners, launched a concept-to-commercialization medtech services platform and acquired three complementary companies: Ximedica, Quartesian, and Boston Healthcare Associates. The combined business brings design and engineering, clinical data, regulatory, and market-access/HEOR capabilities together to create an integrated, global medtech service provider.

Veeva Systems Acquires Crossix Solutions for $430 Million

November 1, 2019

Data & Analytics

Veeva Systems acquired Crossix Solutions for $430 million in a transaction announced September 26, 2019 and closed November 1, 2019. Crossix — a privacy-safe patient data and analytics provider headquartered in New York City — will operate as an independent business unit within Veeva, with Crossix CEO Asaf Evenhaim continuing to lead; certain Crossix employees received long-term equity retention grants valued at about $120 million.

Advarra Acquires Forte

September 5, 2019

Software

Advarra, a leading provider of IRB and research compliance services, announced its intent to acquire Forte, a market-leading provider of clinical research technology including the OnCore CTMS. The deal (Forte sold by Primus Capital) expands Advarra's site-centric technology and eClinical capabilities to better serve academic medical centers, cancer centers, and health systems.

Evidera (PPD) Acquires Medimix International

May 30, 2019

Data & Analytics

Evidera, a business unit of Pharmaceutical Product Development (PPD), has agreed to acquire Medimix International to expand its real-world evidence (RWE) technology and data capabilities. The deal brings Medimix's LiveTracker cloud platform and access to a panel of ~2.2 million clinicians into Evidera's offerings to better support pharmaceutical, diagnostic and medical device clients.

ADVI Health Acquires Partnership for Health Analytic Research (PHAR)

August 23, 2024

Healthcare Services

ADVI Health has acquired Partnership for Health Analytic Research (PHAR), a global HTA and HEOR consultancy with roughly 20 years of experience delivering real-world evidence, patient registries, and value strategy research for biopharma clients. The acquisition expands ADVI’s Strategic Analytics, Value and Economics (SAVEs) capabilities—bringing PHAR’s HEOR and implementation science expertise into ADVI’s market access and commercialization services.